These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3720845)
1. New dihydropyridine drug, nilvadipine, blocks the calcium slow action potential in rat-cultured aortic smooth muscle cells. Bkaily G; Molyvdas PA; Ousterhout J; Sperelakis N Eur J Pharmacol; 1986 May; 124(1-2):59-65. PubMed ID: 3720845 [TBL] [Abstract][Full Text] [Related]
2. Effects of calcium antagonistic drugs on the electrical activity of rabbit sino-atrial node. Molyvdas PA; Sperelakis N Br J Pharmacol; 1986 May; 88(1):249-58. PubMed ID: 3708217 [TBL] [Abstract][Full Text] [Related]
3. Prolonged inhibitory effects of nilvadipine (FR34235) following washout in isolated rabbit aorta and mesenteric artery. Furuta T J Cardiovasc Pharmacol; 1988 Feb; 11(2):134-8. PubMed ID: 2452305 [TBL] [Abstract][Full Text] [Related]
4. Depression of contractions of rabbit aorta and guinea pig vena cava by mesudipine and other slow channel blockers. Sperelakis N; Mras S Blood Vessels; 1983; 20(4):172-83. PubMed ID: 6601967 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of several calcium antagonistic drugs on the electrical activity of guinea pig Purkinje fibers. Molyvdas PA; Sperelakis N Eur J Pharmacol; 1983 Mar; 88(2-3):205-14. PubMed ID: 6852110 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of FR34235, a new dihydropyridine slow channel blocker, in isolated rabbit myocardium and aorta. Furuta T; Shibata S; Kodama I; Yamada K J Cardiovasc Pharmacol; 1983; 5(5):836-41. PubMed ID: 6195473 [TBL] [Abstract][Full Text] [Related]
7. Nilvadipine: profile of a new calcium antagonist. An overview. Rosenthal J J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101 [TBL] [Abstract][Full Text] [Related]
8. Role of cyclic GMP in inhibitory effects of CD-349 in isolated blood vessels. Miyata N; Yamaura H; Tsuchida K; Otomo S; Miyajima E Gen Pharmacol; 1994 Mar; 25(2):267-73. PubMed ID: 8026725 [TBL] [Abstract][Full Text] [Related]
9. Effects of nilvadipine on the cardiovascular system in experimental animals. Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological characteristics of NP-252, a new dihydropyridine slow Ca2+ channel blocker, in isolated rabbit vascular smooth muscle and guinea pig myocardium: vascular selectivity. Shibata S; Satake N; Kodama I; Hester RK; Wang CG; Jino H; Hojo M; Tatsumi H; Gandhi V; Jones DJ Eur J Pharmacol; 1991 Oct; 203(3):337-44. PubMed ID: 1773820 [TBL] [Abstract][Full Text] [Related]
11. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci. Karaki H; Nagase H; Ozaki H; Urakawa N; Weiss GB Br J Pharmacol; 1986 Oct; 89(2):423-9. PubMed ID: 3779218 [TBL] [Abstract][Full Text] [Related]
12. Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors. Burges RA; Gardiner DG; Gwilt M; Higgins AJ; Blackburn KJ; Campbell SF; Cross PE; Stubbs JK J Cardiovasc Pharmacol; 1987 Jan; 9(1):110-9. PubMed ID: 2434785 [TBL] [Abstract][Full Text] [Related]
13. Bepridil blockade of Ca2+-dependent action potentials in vascular smooth muscle of dog coronary artery. Harder DR; Sperelakis N J Cardiovasc Pharmacol; 1981; 3(4):906-14. PubMed ID: 6167820 [TBL] [Abstract][Full Text] [Related]
14. Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery. Nomoto A; Hirosumi J; Sekiguchi C; Mutoh S; Yamaguchi I; Aoki H Atherosclerosis; 1987 Apr; 64(2-3):255-61. PubMed ID: 3606723 [TBL] [Abstract][Full Text] [Related]
15. Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle. Hagiwara S; Mitsui M; Karaki H Eur J Pharmacol; 1993 Mar; 234(1):1-7. PubMed ID: 7682512 [TBL] [Abstract][Full Text] [Related]
16. Calcium antagonistic drugs differ in ability to block the slow Na+ channels of young embryonic chick hearts. Kojima M; Sperelakis N Eur J Pharmacol; 1983 Oct; 94(1-2):9-18. PubMed ID: 6317401 [TBL] [Abstract][Full Text] [Related]
17. The inhibitory action of FR 34235 (a new Ca2+ entry blocker) as compared to nimodipine and nifedipine on the contractile response to norepinephrine, potassium and 5-hydroxytryptamine in rabbit basilar artery. Takagi T; Satake N; Shibata S Eur J Pharmacol; 1983 Jun; 90(2-3):297-9. PubMed ID: 6873189 [TBL] [Abstract][Full Text] [Related]
18. Effects of a new dihydropyridine calcium antagonist on vascular smooth muscles, cardiac muscles and [3H]-nitrendipine binding. Miura A; Ukai Y; Matsuzaki T; Taniguchi N; Hayashi S; Kano S; Kimura Y; Kimura K; Enomoto H Arzneimittelforschung; 1986 Sep; 36(9):1323-8. PubMed ID: 3790181 [TBL] [Abstract][Full Text] [Related]
19. Effect of nilvadipine on the voltage-dependent Ca2+ channels in rat hippocampal CA1 pyramidal neurons. Ishibashi H; Murai Y; Akaike N Brain Res; 1998 Nov; 813(1):121-7. PubMed ID: 9824683 [TBL] [Abstract][Full Text] [Related]
20. Actions of a new Ca2+ channel antagonist, CD832, on two types of Ca2+ channels in smooth muscle. Hirakawa Y; Kuga T; Kanaide H; Takeshita A Eur J Pharmacol; 1994 Feb; 252(3):267-74. PubMed ID: 8162949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]